Cleo Diagnostics Ltd (ASX:COV)
Australia flag Australia · Delayed Price · Currency is AUD
0.3400
0.00 (0.00%)
Last updated: Aug 28, 2026, 2:11 PM AEST

Cleo Diagnostics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
1.721.720.850.21--
Revenue Growth
-32.98%103.17%300.91%---
Gross Profit
1.721.720.850.21--
Operating Income
-5.68-5.68-4.08-3.64-1.7-0.07
Net Income
-5.94-5.94-4-3.76-1.73-0.08
Earnings Per Share
-0.04-0.04-0.03-0.03-0.07-
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
6.226.226.469.370.24-
Total Debt
----1.6-
Net Cash (Debt)
6.226.226.469.37-1.36-
Net Cash Growth
-33.97%-3.66%-31.07%---
Net Cash Per Share
0.050.050.050.08-0.05-

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-4.94-4.94-2.9-2.03-0.68-
Capital Expenditures
-0.01-0.01-0.01-0-0.04-
Free Cash Flow
-4.95-4.95-2.91-2.03-0.72-
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
-330.81%-330.81%-483.01%-1727.45%--
Pretax Margin
-345.72%-345.72%-473.17%-1783.22%--
Profit Margin
-345.72%-345.72%-473.17%-1783.22%--
FCF Margin
-288.09%-288.09%-344.57%-964.47%--

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
27.1539.9259.30207.25--